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Abstract
Background: Quercetin is a natural polyphenolic compound currently under study for its ergogenic capacity to
improve mitochondrial biogenesis. Sedentary mice have exhibited increased endurance performance, but results
are contradictory in human models.
Methods: We examined the effects of six weeks of endurance training and quercetin supplementation on markers
of endurance performance and training in a rodent model. Rats were randomly assigned to one of the following
groups: placebo+sedentary (PS), quercetin+sedentary (QS), placebo+endurance training (PT) and quercetin
+endurance training (QT). Quercetin was administered at a dose of 25 mg/kg on alternate days. During six weeks of
treatment volume parameters of training were recorded, and after six weeks all groups performed a maximal
graded VO2 max test and a low-intensity endurance run-to-fatigue test.
Results: No effects were found in VO2 peak (p>0.999), nor in distance run during low-intensity test, although it was
14% greater in QT when compared with PT (P = 0.097). Post-exercise blood lactate was increased in QT when
compared with PT (p=0.023) and also in QS compared with PS (p=0.024).
Conclusions: This study showed no effects in VO2 peak, speed at VO2 peak or endurance time to exhaustion after
six weeks of quercetin supplementation compared with placebo in trained rats. Quercetin was show to increase
blood lactate production after high-intensity exercise.
Background
Flavonoids are a large family of phenolic compounds or
polyphenols with wide therapeutic applications [1].
Quercetin is one of the most widely spread naturally oc-
curring flavonoids, found in onions, garlic, cabbage, leek,
broccoli, apples, blueberries, tea and red wine [2]. It is
known that quercetin may exhibit anti-oxidant proper-
ties due to its chemical structure, particularly the pres-
ence and location of the hydroxyl (-OH) substitutions
[3]. Despite the fact that after long-term intake there is a
wide distribution of quercetin (including its metabolites)
in all tissues [4], toxic effects have not been reported
until the dose reached 157 mg per kg/d [5].
Quercetin might improve endurance performance
since it is known that some polyphenols like quercetin
[6] and resveratrol [7] improve aerobic capacity of skel-
etal muscle by promoting mitochondrial biogenesis in
mice. A psychostimulant effect of quercetin has also
been reported in vitro [8] in a manner similar to that of
caffeine [9], but this effect was not found in human sub-
jects [10]. Quercetin has also been shown to reduce ill-
ness after strenuous exercise [11], as corroborated by
Davis et al. [12] in a mice model. However, these anti-
inflamatory effects seen in vivo are not as powerful as
those previously described in vitro [13]. The differences
are even greater when the in vivo data is obtained from
athletes [14-16].
Quercetin supplementation improves running time to
fatigue by stimulating mitochondrial biogenesis in mice
[6]. However, this effect has not been observed in
humans [16-18]. Research has shown improvements of
3.9% in VO2 peak and 13.2% in time to fatigue [19], as
well as 2.9% in a maximal 12-minute test after an hour
of preload [18] in untrained subjects. These findings are
in contrast to those of previous studies [11,17,20]. When
athletes are studied, most research has failed to find an
ergogenic effect [15,16], in contrast to that of a study of
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elite cyclists, who exhibited an improvement of their aer-
obic performance [21]. Finally, effects of quercetin on
pre-exercise and post-exercise blood lactate have not
been reported [22].
Based on the data provided, the question arises: could
quercetin be an ergogenic supplement for athletes or un-
trained subjects? Our primary goal is to study, for the
first time and using a rat model, the effects of both en-
durance training and chronic quercetin supplementation
on 1) endurance capacity, VO2 peak, and lactate pro-
duction, 2) endurance training progress, and 3) distance
covered in a low-intensity treadmill test and in a high-
intensity treadmill test.
Methods
Animals and experimental design
Thirty-three young (three week old) male Wistar rats
were randomly allocated into four groups: quercetin and
endurance training (QT, n=9), placebo and endurance
training (PT, n=8), quercetin and sedentary (QS, n=8),
and placebo and sedentary (PS, n=8). Animals, with an
initial body weight of 150 (SD=10) g, were housed in in-
dividual stainless steel metabolism cages. The cages
were located in a well-ventilated thermostatically con-
trolled room (21 ± 2°C), with relative humidity ranging
from 40 to 60%. A reverse 12 h light-12 h dark cycle
(08.00-20.00 hours) was implemented to allow exercise
training during the day. Throughout the experimental
period, all rats consumed water and food ad libitum.
Two weeks before the experimental period, rats were
allowed to adapt to the diet and experimental condi-
tions, and a week before the experimental period, rats
had three days of acclimation to the treadmill. Body
weight was measured twice per week during this time.
After six weeks of treatment we performed two different
exercise tests. Tests were carried out after the treatment
so that we could compare four different conditions
without assessing the effect of training. The reason for
choosing a rat model is that a previous study showed that
sedentary mice exhibited higher endurance performance
with quercetin intake than with placebo [6]. All experi-
ments were undertaken according to the Directional
Guides Related to Animal Housing and Care (European
Community Council, 1986), and all procedures were
approved by the Animal Experimentation Ethics Com-
mittee of the University of Jaén.
Quercetin treatment
Rats were supplemented, during the training period, with
quercetin (QU995; Quercegen Pharma, Newton, MA,
USA) on alternate days at a dose of 25 mg/kg. This dose
has been reported to improve mitochondrial biogenesis
and endurance capacity in sedentary mice [6]. Quercetin
was diluted in a 1% solution of methilcellulose, and was
administered using a metal gavage. Oral gavage was per-
formed to ensure that 25 mg/kg of quercetin was intro-
duced into the stomach. Quercetin also contained
vitamins B3 and C, which have been shown to increase
the bioavailability of quercetin (personal communication,
Quercegen Pharma). The PT and PS groups were also
supplemented with methilcellulose and vitamin B3 and C
with the same concentration as in QTand QS.
Training protocol
Trained animals were exercised five days per week dur-
ing six weeks on a motorized treadmill (Panlab TREAD-
MILLS for five rats LE 8710R). We followed a
modification of the protocol of Davies et al [23]. Animals
ran at a constant speed of 44 cm/s and at 10% grade.
The first day's training session was 20-minutes long, and
every two days the work period was increased by five
minutes. On the last day of the fifth week they were
required to run for a full 80 minutes. This work duration
was maintained during the sixth week. The untrained
group was exercised at the same speed and grade for
only 10 minutes twice per week, in order to ensure that
they were able to perform the tests performed at the end
of the treatment.
Twenty-four hours after the last training session, all
animals performed a graded high-intensity treadmill test
to determine VO2 peak using a treadmill gas analyzer
(Model LE405, Panlab/Harvard Apparatus) previously
calibrated with mixtures of O2 and CO2 at different
concentrations. After an initial two minutes with no
grade at 22 cm/s, treadmill speed was increased by
11 cm/s every two minutes. The test was finished when
the rat was exhausted and located at the end of the
treadmill, on the shock bar, for 5 seconds, when rats
were quickly removed [24]. VO2 peak was defined as the
highest 20” interval recorded during the test. Blood lac-
tate was measured before and immediately after the test
using a Lactate-Pro analyzer, blood was taken from a
small cut in the rat's tail.
After twenty-four hours of recovery a low-intensity en-
durance test was performed. Each rat was required to
run to exhaustion at 44 cm/s at a 10% grade. The test
finished when the animal was visibly exhausted, not able
to maintain the appropriate pace, and this resulted in a
rising frequency of landings on the electrical shock grid
[24]. The endpoint was marked by the rat's inability to
return to the treadmill belt, and to stand on a flat
surface.
Statistical methods
Treatment effect between trained (QT vs PT) and seden-
tary (QS vs PS) groups was analyzed with a t test for in-
dependent samples, using study groups as independent
variables and each of the performance parameters
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measured as dependent variables (Weight, VO2 peak,
vVO2 peak, maximum speed achieved, time of endur-
ance test, distance run and distance run until RQ= 1,
and VO2 at exhaustion). Lactate production measured
before and after the maximal incremental treadmill test
was analyzed using a two-way repeated measures
ANOVA, with groups as between-subject variable and
exercise time as within-subject variable. When the effect
was significant, post hoc analysis was performed and ad-
justment done through the Bonferroni confidence inter-
val. The level of significance was P≤0.05 for the t-test
and P≤0.008 in post hoc Bonferroni's comparisons
(P=0.008 needed for significance with an experiment-
wise alpha of 0.05 using Bonferroni adjustment in alpha
for six comparisons). All analyses were performed using
the Statistical Package for Social Sciences (SPSS, version
19.0 for Windows; SPSS, Inc., Chicago, IL, USA).
Results
Training progress
The training protocol and the effect of time on the meters
run is presented in Figure 1. The QT and PT groups were
subjected to a six-week duration training with an increase
of five minutes every two days up to a maximum of
80 minutes, which represented an average increase of the
load between intervals of 11.9 and 10.6% in QTand PT re-
spectively. The final training volume increased by 399% to
349% in QT and PT compared with baseline. There were
no differences in the distance run by the two groups at
any time of training (P> 0.05). The average/day of meters
walked were 986 and 1002 in the QT and PT groups re-
spectively. Although the relationship between training
time and distance covered showed an almost linear fit in
both groups (R2 = 0.992 and 0.986) for QT and PT re-
spectively, there was a sligh improvement in the perform-
ance of the QT group.
Endurance capacity
There were no significant difference in exercise perform-
ance between the quercetin and placebo trials. Although
the QTgroup ran for 5.91% longer (Figure 2) and 14% fur-
ther (Figure 3B) than the PT group, there were no signifi-
cant differences in either time [P=0.351, Power=0.147] or
distance [P=0.051, Power=0.512)].
Maximal incremental test
During the incremental test VO2 peak, speed at VO2
peak and maximum speed achieved did not differ be-
tween quercetin and placebo conditions (Table 1). There
were no differences between the final weight after treat-
ment, as shown in Table 1. Although the distance
achieved by QT was 18.6% greater than PT this result
was not significant [P=0.102, Power=0.380] (Figure 3A).
Figure 4B shows that the QT group ran for 56.1% longer
before reaching RQ=1 compared with the PT group, but
this effect was not significant [P=0.222, Power=0.213].
Similar results are illustrated by Figure 4A, in which VO2
at exhaustion does not differ after the high-intensity
test for the quercetin and placebo exercise groups
(P=0.069, Power=0.448). Lactate production was ana-
lyzed (pre- and post-high-intensity test) using repeated
measures ANOVA, where we observed a group effect
P=0.001, Power=0.967 and a group interaction per time
unit P=0.001, Power=0.977. Specifically, lactate production
Figure 1 Training protocol of six weeks for rats. No significant difference (P>0.05) in distance run between QT and PT at any stage of training.
‘ = Minutes, Aver = Average, T= Application of tests. The percentage of increase in distance run was computed as ((interval - previous interval) /
previous interval) x 100.
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immediately after the high-intensity test was increased in
the QT and QS groups compared with the PT and PS
groups (P=0.004) [Figure 5]. No differences were found in
lactate production between groups prior to the high-
intensity test (P>0.05). Lactate production was signifi-
cantly increased in each group (P<0.001 in QT, QS y PS)
and (P=0.004 in either PT) at the end of the high-intensity
test (data not shown).
Discussion
A recent study evaluated the effects of short-term quercetin
supplementation on exercise performance in mice [6] and
demonstrated a significant increase in endurance capacity
and mitochondrial biogenesis in comparison with placebo
groups. Using a rat model, no significant performance effect
(VO2 peak, endurance capacity and training parameters)
was measured in trained rats with a quercetin dose of
25 mg/kg on alternative days compared with placebo.
The endurance training protocol used in this study was
a modification of a widely used protocol in the literature
[23,25,26]. As shown in Figure 1, distance run increased
with time. These data suggest that the training workload
was well adjusted, since a plateau in the training volume is
a sign of overtraining [27]. No difference was found in the
average daily distance run between the QT and PT groups.
VO2 peak values in rats vary depending on the methodo-
logical test used or on their weight [28]. Our results show
that six weeks of quercetin supplementation did not in-
crease VO2 peak or VO2 at exhaustion in sedentary or
trained rats. It must be noted that our protocol did no
alter inclination in order to examine the maximum speed
achieved. Protocols that do not use an incline are known
to induce a lower VO2 peak than others with 15°-20° in-
clination [28,29]. However, our results were similar to
those recently reported [17], but were in contrast with the
ones that reported an increase of VO2 peak by quercetin
in sedentary humans [19]. Speed at VO2 peak was also
analyzed in this experiment, with no change reported in
the quercetin groups. We hypothesized that quercetin
would increase VO2 peak due to its ability to increase mito-
chondrial biogenesis in mice (6). However, as described
above, no differences were observed in any groups on mea-
sures related to oxygen uptake by quercetin supplementa-
tion. These results are similar to those obtained by
Bigelman et al [30]. There are several potential reasons for
these results: firstly, VO2 peak is influenced by muscle
mitochondrial oxidative capacity, but relative to endurance
capacity, it is limited to a greater extent by oxygen delivery
via the cardiovascular system [31]. Secondly, larger doses
over extended periods using added flavonoids such as eppi-
gallocatechin gallate (EGCG) may augment quercetin's
effects on mitochondrial biogenesis. This could be a more
appropriate supplement to increase oxygen consumption
[16]. However, previous work did not find any ergogenic
effect of quercetin and EGCG supplementation in a moder-
ately trained sample [30].
Figure 2 Time run until exhaustion in the low-intensity
endurance regime. T- test for independent samples reported no
significant differences between QT and PT or QS and PS (P>0.05).
Figure 3 Distance run until exhaustion in A) high-intensity incremental test and B) low-intensity endurance test. T-test for independent
samples reported no significant differences between QT and PT or QS and PS (P>0.05).
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To examine additional ergogenic effects of quercetin
in rats, oxygen consumption and carbon dioxide produc-
tion were measured during the incremental exercise test.
This enabled the calculation of RQ. In all groups of rats,
the average RQ remained fairly constant and did not dif-
fer between groups (data not shown). When VCO2 is
greater than VO2 (RQ>1.0), this point of inflection is
correlated with blood lactate accumulation [32]. QT
group showed a trend to run longer before reaching an
RQ of 1.0 (Figure 4B) indicating that these rats were able
to use oxidative metabolism for a longer period.
Fatigue in the endurance test is thought to arise pri-
marily from limitations in the periphery, like the cardio-
vascular system and muscles [6]. Although it has been
reported that antioxidant supplementation may decrease
endurance performance [25], the trained groups showed
an increase in time to fatigue of 244.96% and 244.93%
for QT and PT respectively when compared to PS. How-
ever, in contrast with others [6], we did not observe an
improvement in QS. When compared to trained groups,
there was a non-significant increase of 5.91% in the QT
group in time to fatigue. Despite being non-significant,
this result was related to recently published results by
Kesser et al. [33].
We employed two different types of exercise (a low in-
tensity endurance capacity test and a maximal graded in-
tensity test). Although both are commonly used exercise
models, the stimuli are totally different. During the tread-
mill running endurance test mice run at a given intensity
until they can no longer maintain the pace and end up on
the electrical shock grid [24,25]. The performance in this
type of exercise is known to be related to the oxidative cap-
acity of muscles. However, during the maximal progressive
intensity test, rats achieved higher velocities, a performance
reflecting their capacity to use glycogen as a source of fuel.
Distance run to exhaustion was recorded during these two
different regimes (Figure 3). Under the high-intensity re-
gime (test used to analyze oxygen consumption) the QT
group ran (18,6%) longer than PT. Under the low-intensity
regime (endurance test) QT ran 14% (p=0.097) further
than PT. These results were not significant, however they
demonstrated a trend that may become significant after a
longer treatment.
Although no effects have been previously reported
[22], the present study demonstrated that quercetin had
an effect on blood lactate immediately after exhaustion.
When the QT and QS groups reached exhaustion, their
blood lactate levels were elevated when compared with
Table 1 Mean value (standard deviation) after incremental maximal test
Trained Sedentary
QT PT t df P Power QS PS t df P Power
WEIGHT (g) 352.89±31.25 367.25±24.41 1.045 15 0.312 0.161 379.25±52.91 366.63±8.97 0.595 7.298 0.570 0.086
VO2MAX
(ml/kg/min)
63.55±8.58 58.62±7.38 1.272 14.990 0.223 0.219 65.12±8.21 61.87±5.51 0.929 14 0.369 0.139
/vVO2MAX
(cm/s)
47.89±8.17 48.50±16.18 0.100 15 0.922 0.051 46.88±13.21 46.63±10.98 0.041 14 0.968 0.052
MAX. VEL
(cm/s)
95.11±7.40 87.50±9.65 0.837 15 0.086 0.405 71.63±8.68 71.63±11.01 0.002 14 0.998 0.050
Compared values for trained (QT vs PT) and sedentary groups (QS vs PS). T-test for independent samples reported no significant differences between QT and PT or QS
and PS. VO2 MAX: Maximum oxygen uptake; vVO2 MAX: Velocity at VO2 max; MAX.VEL: Maximal velocity achieved. df: degrees of freedom. Power: statistical power.
Figure 4 A) VO2 at the end of the high-intensity incremental test B) Distance run until RQ=1. T-test for independent samples reported no
significant differences between QT and PT or QS and PS (P>0.05).
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PT and with PS respectively (Figure 5). These elevated
blood lactate levels were an indication of enhanced gly-
colysis and lactate production in the skeletal muscle [30]
in the quercetin supplemented groups that had run to
exhaustion. However, there are other possible reasons
that may explain the quercetin effects in addition to
improvements in glycolytic flux. The psychostimulant
effects of quercetin [8] could increase effort at high in-
tensities and this could result in an increased lactate
production. However, further experiments may corrob-
orate this quercetin effect by measuring glycogen deple-
tion in muscle and liver during high-intensity exercise.
In summary, no effects were measured in VO2 peak,
speed at VO2 peak or endurance time to exhaustion
after six weeks of quercetin supplementation compared
with placebo in trained rats. No effects were found ei-
ther in sedentary rats supplemented with quercetin com-
pared with placebo. However, a trend was visible
regarding increased performance by quercetin supple-
mentation in some parameters like distance run until ex-
haustion or distance run until RQ=1. Perhaps after
longer treatment, like eight or ten weeks, this effect
could be significant. For the first time we have detected
an increase in blood lactate production by quercetin, al-
though more research is needed on this topic. No effects
on exercise performance were found but this will need
to be verified by further studies examining muscle
physiology.
Limitations and strengths
The present study has several limitations that must be
mentioned. First, the present physiological results obtained
in rats must be confirmed in human subjects after long-
term quercetin ingestion, since our results cannot be
extrapolated to the potential effects over months in
trained human subjects. Also, there is a lack of evidence
regarding how much quercetin must be supplemented
for it to exert its ergogenic effects, although 25 mg/kg is
thought to be a good start. In addition, the six-week
protocol applied may be insufficient to observe any
ergogenic effect, and in fact there are some parameters
that started exhibiting a trend and might be significant
after 8-13 weeks of treatment. Finally, the lower statis-
tical power observed in most of our results suggests to
be cautious in interpreting them, future research with
larger samples are needed to draw definitive conclu-
sions. On the other hand, this is the first research that
has analyzed the effect of quercetin on both sedentary
and trained rats, hopefully paving the road for studies
intended to find out if quercetin supplementation can
enhance performance in trained athletes.
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